StockWatch
·
Other Pharmaceuticals
AGM/EGMJun 29, 2026, 04:21 PM

Synergy CHC Stockholders Approve Reverse Split, Equity Plan

AI Summary

Synergy CHC Corp. held its 2026 annual meeting of stockholders on June 29, 2026, where several key proposals were approved. Stockholders voted to approve a reverse stock split with an aggregate ratio not exceeding 1-for-200. Additionally, an amendment to the 2024 Equity Incentive Plan was approved, increasing the shares available for issuance to 150,000,000 and permitting repricing of outstanding awards. The meeting also saw the election of five directors, the ratification of RBSM LLP as the independent auditor, and the approval of the full issuance of shares for the Lender Warrant.

Key Highlights

  • Stockholders approved a reverse stock split with an aggregate ratio not exceeding 1-for-200.
  • The 2024 Equity Incentive Plan was amended to increase available shares to 150,000,000.
  • The 2024 Equity Incentive Plan amendment also permits repricing of outstanding awards.
  • Five directors were elected to serve until the 2027 annual meeting.
  • RBSM LLP was ratified as the independent auditor for fiscal year ending December 31, 2026.
  • Stockholders approved the full issuance of shares for the Lender Warrant to comply with Nasdaq rules.
  • A quorum was present with 9,808,119 votes, representing approximately 65% of outstanding shares.